Free

FreeIn Brief

St. Jude marathon raises $10 million

ST. JUDE MEMPHIS MARATHON WEEKEND Dec. 3 raised $10 million for St. Jude Children’s Research Hospital. Over the past 15 years, participants running as St. Jude Heroes have joined the fight against childhood cancer and raised more than $60 million to support St. Jude. About 23,000 people took part in the race that drew 40,000 […]
Drugs & TargetsFree

Whole genome sequencing center established in Singapore

NOVOGENE, a commercial provider of genomic services, AITbiotech Pte Ltd, a Singapore biotechnology company, and the Genome Institute of Singapore announced that NovogeneAIT Genomics Singapore–a new joint venture between Novogene and AITbiotech–will establish a joint whole genome sequencing center at Biopolis, Singapore. The new center will provide Illumina HiSeq X based whole genome sequencing and […]
FreeIn Brief

AbbVie, Northwestern and Hopkins announce collaborations

AbbVie signed separate five-year collaboration agreements with two cancer centers: the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Johns Hopkins University School of Medicine. The agreements are intended to advancing research and discovery in oncology. AbbVie and Northwestern will work in several areas of oncology research, which could include, lung, colorectal, […]
FreeIn Brief

GW launches the GW Cancer Center

GEORGE WASHINGTON UNIVERSITY has formally launched the GW Cancer Center. The GW Cancer Center is a collaboration between GW Hospital, The GW Medical Faculty Associates, the GW School of Medicine and Health Sciences, and the Milken Institute School of Public Health at GW, to expand GW’s efforts in the fight against cancer. The GW Cancer […]
FreeIn Brief

Parker Institute, CRI form collaboration on neoantigens

THE PARKER INSTITUTE for Cancer Immunotherapy and the Cancer Research Institute announced a Collaboration focused on neoantigens. The search for these unique cancer markers has become a robust area of research as scientists believe they may hold the key to developing a new generation of personalized, targeted cancer immunotherapies. The collaboration, the Tumor neoantigEn SeLection […]